Oruka Therapeutics ORKA
NASDAQ ORKA
$82.15 -2.04 (-2.42%)
At close: Sep 29, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Operating Leases (2020 - 2026)

Updated

Oruka Therapeutics (ORKA) recorded Operating Leases of $1.88 million in Q2 2026, up 12.7% from $1.67 million a year earlier and up 66.5% from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Operating Leases (2020 - 2026) Analysis & Trends

At the end of FY2025, Oruka Therapeutics reported Operating Leases of $1.31 million, up 73.9% from FY2024.

  • Annual Operating Leases has a five-year compound annual growth rate of 26.3% (FY2020 to FY2025).
  • Across earlier years, Operating Leases came in at $755,000 in FY2024 (+270.1%), $204,000 in FY2023 (-27.1%), $280,000 in FY2022 (-26.9%) and $383,000 in FY2021 (-6.4%).
  • The Q2 2026 figure is the highest quarterly Operating Leases in data going back to Q4 2020.
  • On a year-over-year basis, Operating Leases has increased for four consecutive quarters, with growth averaging 129.9% over the last six quarters.
  • Peak year-over-year performance for Operating Leases in the last five years was growth of 275.9% in Q3 2024, against a decline of 27.1% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.13 million (Q1 2026), $1.31 million (Q4 2025) and $1.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Oruka Therapeutics 5.29 Bn 3.34 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.88 Mn
Mar 31, 2026 1.13 Mn
Dec 31, 2025 1.31 Mn
Sep 30, 2025 1.49 Mn
Jun 30, 2025 1.67 Mn
Mar 31, 2025 664,000.00
Dec 31, 2024 755,000.00
Sep 30, 2024 842,000.00
Dec 31, 2023 204,000.00
Sep 30, 2023 224,000.00
Jun 30, 2023 243,000.00
Mar 31, 2023 262,000.00
Dec 31, 2022 280,000.00
Sep 30, 2022 301,000.00
Jun 30, 2022 329,000.00
Mar 31, 2022 357,000.00
Dec 31, 2021 383,000.00
Sep 30, 2021 410,000.00
Jun 30, 2021 435,000.00
Mar 31, 2021 394,000.00
API Access

Oruka Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ORKA&period=max&api_key=YOUR_API_KEY